According to the 2 industry analysts covering Ekso Bionics Holdings, the consensus is that breakeven is near. They expect the company to post a final loss in 2026, before turning a profit of US$5.4m ...
Research analysts at StockNews.com began coverage on shares of Ekso Bionics (NASDAQ:EKSO – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “hold” ...
Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced ...
SAN RAFAEL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and ...